Skip to search formSkip to main contentSkip to account menu

cyclophosphamide/doxorubicin/methotrexate protocol

Known as: CAM combination, CTX/DOX/MTX, Cyclophosphamide/Doxorubicin/Methotrexate 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (3)

Antineoplastic Combined Chemotherapy ProtocolsCyclophosphamideMethotrexate
DoxorubicinDoxorubicin Hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2005
Review
2005
Intraocular lymphoma as a masquerade syndrome complicating cerebral lymphoma of the corpus callosum
Cerebral lymphoma and intraocular lymphoma (IOL) are both uncommon lymphomas with poor prognosis. Concurrent or sequential… 
1997
1997
Suppression of acute experimental allergic encephalomyelitis in Lewis rats with a mycophenolic acid derivative.
Oral administration of ethyl O-[N-(p-carboxyphenyl-carbamoyl]-mycophenolate (CAM), a derivative of mycophenolic acid (MPA) and an… 
Highly Cited
1975
Highly Cited
1975
Thyroiditis in T cell-depleted rats. Influence of strain, radiation dose, adjuvants and antilymphocyte serum.
Strain differences in susceptibility to the development of thyroiditis following adult thymectomy and repeated sublethal X… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)